Welcome to our dedicated page for IDEX SEC filings (Ticker: IEX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to IDEX Corporation (NYSE: IEX) SEC filings, offering investors a primary source of regulatory information about the global engineered products company. IDEX files a variety of documents with the U.S. Securities and Exchange Commission that detail its financial performance, segment results, capital allocation decisions and governance matters.
Through Forms 10-K and 10-Q, investors can review consolidated and segment-level data for the Health & Science Technologies, Fluid & Metering Technologies, and Fire & Safety / Diversified Products segments, along with discussions of pricing, volume trends, acquisitions and non-GAAP measures such as organic sales, adjusted EBITDA and free cash flow. Current reports on Form 8-K, several of which are reflected in the recent filings list, disclose material events including quarterly earnings announcements, changes in executive leadership, and share repurchase authorizations.
Filings also identify IDEX’s common stock listing on the New York Stock Exchange under the symbol IEX and provide details on items such as dividend declarations, capital structure and certain compensation arrangements for senior executives. For those monitoring insider activity, Forms 3, 4 and 5 (when available) show transactions by directors and officers in IDEX equity.
On Stock Titan, these documents are supplemented with AI-powered summaries that highlight key points from lengthy filings, helping readers quickly understand segment performance, major risks, capital deployment and notable governance changes. Real-time updates from EDGAR ensure that new IDEX filings, from quarterly reports to event-driven 8-Ks, appear promptly, giving investors and researchers an efficient way to follow the regulatory record behind IEX stock.
IDEX Corp Schedule 13G/A: The Vanguard Group states it beneficially owns 0 shares of IDEX Corp common stock and reports 0% ownership. The filing explains an internal realignment effective January 12, 2026 that caused certain Vanguard subsidiaries/divisions to report separately under SEC Release No. 34-39538. The filing is signed by Ashley Grim on 03/27/2026.
IDEX Corporation is soliciting proxies for its 2026 virtual annual stockholders meeting on May 6, 2026 at 9:00 a.m. Central Time. Holders of common stock as of March 12, 2026 can attend and vote online using a 16-digit control number.
Stockholders will vote on electing four Class I directors for three-year terms, an advisory approval of named executive officer compensation, and ratification of Deloitte & Touche LLP as independent auditor for 2026. The Board recommends voting FOR all three proposals.
The proxy details a 10‑member, largely independent Board, its committee structure, governance practices, risk and cybersecurity oversight, and sustainability program. It also explains director compensation, stock ownership guidelines, and the executive compensation framework, including incentive plans, peer benchmarking, and use of an independent compensation consultant.
IDEX CORP executive Tara M. Tereso reported equity compensation changes and related tax withholding. On February 19, 2026, she acquired an award of 1,055 shares of common stock and 4,445 stock options at an exercise price of $0.0000 per option, described as grants or awards. The restricted shares vest in three roughly equal annual installments beginning February 19, 2027, and the options vest in four roughly equal annual installments beginning the same date, in each case conditioned on continued service.
On February 23, 2026, 154 shares of common stock were disposed of at a price of $207.48 per share to satisfy tax withholding obligations, a non‑market “F” code transaction. After these transactions, Tereso directly held 5,836 shares of common stock and 4,445 options.
Simmons William L. reported acquisition or exercise transactions in this Form 4 filing.
IDEX CORP officer William L. Simmons reported equity awards rather than open-market trades. On February 19, 2026, he received options to buy 4,445 shares of common stock and an award of 1,055 restricted stock units. The RSUs each represent a right to one share of common stock and vest in three substantially equal annual installments beginning February 19, 2027, contingent on continued service. The stock options vest in four substantially equal annual installments beginning on the same date, also subject to his continued service.
IDEX CORP reported insider equity awards and a related tax share disposition for Vice President and Chief Accounting Officer Allison S. Lausas.
On February 19, 2026, Lausas received a grant of 275 shares of common stock and an award of 1,145 stock options, both at a stated price of $0.0000 per share. The restricted shares vest in three substantially equal annual installments beginning February 19, 2027, while the options vest in four substantially equal annual installments beginning the same date, in each case subject to continued service.
On February 20, 2026, Lausas disposed of 179 shares of common stock at $207.86 per share in a tax-withholding disposition. Following these transactions, she directly owned 3,947 shares of common stock and 1,145 stock options.
Gillen Sean M. reported acquisition or exercise transactions in this Form 4 filing.
IDEX CORP reported that its SVP and Chief Financial Officer, Sean M. Gillen, received new equity awards. He was granted 10,160 options to buy common stock and 2,410 restricted shares on February 19, 2026. The restricted shares vest in three substantially equal annual installments beginning February 19, 2027, conditioned on his continued service. The stock options vest in four substantially equal annual installments starting on the same date, also subject to his continuous employment. These awards increase his direct equity stake in the company and are designed to align his compensation with long-term company performance.
ASHLEMAN ERIC D reported acquisition or exercise transactions in this Form 4 filing.
IDEX CORP CEO and President Eric D. Ashleman reported equity awards rather than open-market trades. He received 38,165 options to buy IDEX common stock and a separate grant of 9,040 shares of common stock, awarded at a stated price of $0.00 per share as compensation.
The 9,040-share award represents restricted stock units, each convertible into one share of common stock. These RSUs vest in three substantially equal annual installments beginning February 22, 2027, conditioned on his continued service. The stock options vest in four substantially equal annual installments starting on the same date, also subject to continued service.
Anderson Lisa M reported acquisition or exercise transactions in this Form 4 filing.
IDEX CORP senior executive Lisa M. Anderson, who serves as SVP, General Counsel, Chief Administrative Officer and Corporate Secretary, reported equity compensation awards. She received options for 5,080 shares of common stock and a grant of 1,205 restricted shares, both at a price of $0.00 per share as part of her compensation.
The restricted shares vest in three substantially equal annual installments starting on February 19, 2027, contingent on her continuous service. The stock options vest in four substantially equal annual installments beginning on the same date, also conditioned on continued service. After these awards, she directly holds 4,327 common shares and 5,080 options.